{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:21:37Z","timestamp":1791580897045,"version":"4.3.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Health Sciences"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Inflammatory rheumatic diseases (IRDs) present substantial risks of infection-related comorbidities during pregnancy. This study evaluates the knowledge, experience, and perceptions of healthcare professionals concerning the prevention of these risks. An international, cross-sectional survey was administered using the SurveyMonkey platform. The survey was disseminated to healthcare professionals specializing in rheumatology, obstetrics, infectious diseases, internal medicine, general practice, and related disciplines through social media channels. Developed in accordance with European Alliance of Associations for Rheumatology (EULAR) recommendations, this survey comprised 30 questions, including multiple-choice, Likert-type, and open-ended formats. A total of 201 healthcare professionals from thirty-six countries participated in the study, with rheumatologists comprising the majority (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009145, 72.1%). Systemic lupus erythematosus (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009183), systemic vasculitis (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009141), and rheumatoid arthritis (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200986) were identified as the diseases associated with the highest risk of infection-related comorbidities. The most frequently recommended infectious conditions for screening included Hepatitis B (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009142), urinary tract infections (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009141), and Hepatitis C (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009129). The primary risk factors were uncontrolled disease activity (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009176), high-dose corticosteroid use (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009164), and high disease severity (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009162). The most significant systemic barriers were insufficient number of specialists (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009156), and absence of multidisciplinary teams (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009155). This study identifies structural and educational deficiencies in the management of infection-related comorbidities among pregnant patients with IRD. The results underscore the need for targeted clinical guidelines, enhanced multidisciplinary care models, and expanded pre-pregnancy counseling.\n                  <\/jats:p>","DOI":"10.1007\/s00296-026-06174-5","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T07:23:28Z","timestamp":1781508208000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Healthcare professionals\u2019 knowledge and views on unmet needs in prevention of infectious comorbidities in pregnant women with inflammatory rheumatic diseases"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-5714-2325","authenticated-orcid":false,"given":"Dinara","family":"Yerlanova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4188-8486","authenticated-orcid":false,"given":"Olena","family":"Zimba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9524-2675","authenticated-orcid":false,"given":"Dinara","family":"Makhanbetkulova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3949-2543","authenticated-orcid":false,"given":"Bekaidar","family":"Nurmashev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1749-9739","authenticated-orcid":false,"given":"Mariusz","family":"Korkosz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6065-8002","authenticated-orcid":false,"given":"Burhan Fatih","family":"Kocyigit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"key":"6174_CR1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s43032-022-00901-6","volume":"30","author":"B Grygiel-G\u00f3rniak","year":"2023","unstructured":"Grygiel-G\u00f3rniak B, Masiero E, Nevaneeth BC, Jojy MM (2023) Rheumatic diseases in reproductive age-the possibilities and the risks. Reprod Sci 30:111\u2013123. https:\/\/doi.org\/10.1007\/s43032-022-00901-6","journal-title":"Reprod Sci"},{"key":"6174_CR2","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00296-023-05398-z","volume":"44","author":"A Gupta","year":"2024","unstructured":"Gupta A, De Vera MA, Rebi\u0107 N, Amiri N (2024) Pre-pregnancy planning for female patients seen at a pregnancy and rheumatic diseases clinic: a retrospective analysis of patients with rheumatic diseases seeking pregnancy-related care. Rheumatol Int 44:283\u2013289. https:\/\/doi.org\/10.1007\/s00296-023-05398-z","journal-title":"Rheumatol Int"},{"key":"6174_CR3","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1177\/09612033231176268","volume":"32","author":"H Shimada","year":"2023","unstructured":"Shimada H, Wakiya R, Kameda T et al (2023) Immunological disease activity parameters at conception are risk factors for preterm birth and low birth weight in patients with systemic lupus erythematosus. Lupus 32:833\u2013841. https:\/\/doi.org\/10.1177\/09612033231176268","journal-title":"Lupus"},{"key":"6174_CR4","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1186\/s12884-023-06033-2","volume":"23","author":"J Lv","year":"2023","unstructured":"Lv J, Xu L, Mao S (2023) Association between disease activity of rheumatoid arthritis and maternal and fetal outcomes in pregnant women: a systematic review and meta-analysis. BMC Pregnancy Childbirth 23:724. https:\/\/doi.org\/10.1186\/s12884-023-06033-2","journal-title":"BMC Pregnancy Childbirth"},{"key":"6174_CR5","doi-asserted-by":"publisher","first-page":"102022","DOI":"10.1016\/j.berh.2024.102022","volume":"39","author":"T Nakai","year":"2025","unstructured":"Nakai T, Fukui S, Ozawa H, Kitada A, Okada M, Kishimoto M (2025) Management of pregnant with rheumatoid arthritis: preconception care, pregnancy and lactation strategies, and maternal-fetal outcomes. Best Pract Res Clin Rheumatol 39:102022. https:\/\/doi.org\/10.1016\/j.berh.2024.102022","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"6174_CR6","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/annrheumdis-2016-209770","volume":"76","author":"L Andreoli","year":"2017","unstructured":"Andreoli L, Bertsias GK, Agmon-Levin N et al (2017) EULAR recommendations for women\u2019s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and\/or antiphospholipid syndrome. Ann Rheum Dis 76:476\u2013485. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209770","journal-title":"Ann Rheum Dis"},{"key":"6174_CR7","doi-asserted-by":"publisher","first-page":"j895","DOI":"10.1136\/bmj.j895","volume":"356","author":"RJ Desai","year":"2017","unstructured":"Desai RJ, Bateman BT, Huybrechts KF et al (2017) Risk of serious infections associated with use of immunosuppressive agents in pregnant women with autoimmune inflammatory conditions: cohort study. BMJ 356:j895. https:\/\/doi.org\/10.1136\/bmj.j895","journal-title":"BMJ"},{"key":"6174_CR8","doi-asserted-by":"publisher","first-page":"152603","DOI":"10.1016\/j.semarthrit.2024.152603","volume":"70","author":"C Deffendall","year":"2025","unstructured":"Deffendall C, Green S, Suh A, Nikolova N, Walker K, Whitney R et al (2025) Peripartum maternal outcomes in individuals with systemic lupus erythematosus in a real-world electronic health record cohort. Semin Arthritis Rheum 70:152603. https:\/\/doi.org\/10.1016\/j.semarthrit.2024.152603","journal-title":"Semin Arthritis Rheum"},{"key":"6174_CR9","doi-asserted-by":"publisher","first-page":"e004091","DOI":"10.1136\/rmdopen-2024-004091","volume":"10","author":"L Andreoli","year":"2024","unstructured":"Andreoli L, Gerardi MC, Gerosa M et al (2024) Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospective Italian P-RHEUM.it study. RMD Open 10:e004091. https:\/\/doi.org\/10.1136\/rmdopen-2024-004091","journal-title":"RMD Open"},{"key":"6174_CR10","doi-asserted-by":"publisher","first-page":"e398","DOI":"10.3346\/jkms.2020.35.e398","volume":"35","author":"PS Gaur","year":"2020","unstructured":"Gaur PS, Zimba O, Agarwal V, Gupta L (2020) Reporting survey based studies - a primer for authors. J Korean Med Sci 35:e398. https:\/\/doi.org\/10.3346\/jkms.2020.35.e398","journal-title":"J Korean Med Sci"},{"key":"6174_CR11","doi-asserted-by":"publisher","first-page":"e0194239","DOI":"10.1371\/journal.pone.0194239","volume":"13","author":"T Turk","year":"2018","unstructured":"Turk T, Elhady MT, Rashed S et al (2018) Quality of reporting web-based and non-web-based survey studies: what authors, reviewers and consumers should consider. PLoS ONE 13:e0194239. https:\/\/doi.org\/10.1371\/journal.pone.0194239","journal-title":"PLoS ONE"},{"key":"6174_CR12","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.ard.2025.02.023","volume":"84","author":"L R\u00fcegg","year":"2025","unstructured":"R\u00fcegg L, Pluma A, Hamroun S et al (2025) EULAR recommendations for use of antirheumatic drugs in reproduction, pregnancy, and lactation: 2024 update. Ann Rheum Dis 84:910\u2013926. https:\/\/doi.org\/10.1016\/j.ard.2025.02.023","journal-title":"Ann Rheum Dis"},{"key":"6174_CR13","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1136\/ard-2022-223335","volume":"82","author":"GE Fragoulis","year":"2023","unstructured":"Fragoulis GE, Nikiphorou E, Dey M et al (2023) 2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 82:742\u2013753. https:\/\/doi.org\/10.1136\/ard-2022-223335","journal-title":"Ann Rheum Dis"},{"key":"6174_CR14","first-page":"1014","volume":"36","author":"F Fayad","year":"2018","unstructured":"Fayad F, Ziade N, Karam GA, Ghaname W, Khamashta M (2018) Rheumatic diseases and pregnancy: a national survey about practice patterns among rheumatologists and obstetricians. Clin Exp Rheumatol 36:1014\u20131021","journal-title":"Clin Exp Rheumatol"},{"key":"6174_CR15","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1007\/s40744-022-00488-z","volume":"9","author":"M Olej\u00e1rov\u00e1","year":"2022","unstructured":"Olej\u00e1rov\u00e1 M, Macejov\u00e1 \u017d, Gkalpakiotis S, Proch\u00e1zkov\u00e1 L, T\u00f3th Z, Pr\u00e1gr P (2022) Reproductive healthcare in women with rheumatoid arthritis and psoriatic diseases in routine clinical practice: survey results of rheumatologists and dermatologists. Rheumatol Ther 9:1575\u20131586. https:\/\/doi.org\/10.1007\/s40744-022-00488-z","journal-title":"Rheumatol Ther"},{"key":"6174_CR16","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1136\/annrheumdis-2016-209322","volume":"76","author":"GR Burmester","year":"2017","unstructured":"Burmester GR, Landew\u00e9 R, Genovese MC et al (2017) Adalimumab long-term safety: infections, vaccination response and pregnancy outcomes in patients with rheumatoid arthritis. Ann Rheum Dis 76:414\u2013417. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209322","journal-title":"Ann Rheum Dis"},{"key":"6174_CR17","doi-asserted-by":"publisher","first-page":"e403","DOI":"10.3346\/jkms.2023.38.e403","volume":"38","author":"O Zimba","year":"2023","unstructured":"Zimba O, Gasparyan AY (2023) Designing, conducting, and reporting survey studies: a primer for researchers. J Korean Med Sci 38:e403. https:\/\/doi.org\/10.3346\/jkms.2023.38.e403","journal-title":"J Korean Med Sci"},{"key":"6174_CR18","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.1007\/s10067-020-05173-6","volume":"39","author":"Y El Miedany","year":"2020","unstructured":"El Miedany Y, Palmer D (2020) Rheumatology-led pregnancy clinic: enhancing the care of women with rheumatic diseases during pregnancy. Clin Rheumatol 39:3593\u20133601. https:\/\/doi.org\/10.1007\/s10067-020-05173-6","journal-title":"Clin Rheumatol"},{"key":"6174_CR19","doi-asserted-by":"publisher","first-page":"934","DOI":"10.3899\/jrheum.220773","volume":"50","author":"C Tani","year":"2023","unstructured":"Tani C, Zucchi D, Bellis E et al (2023) Patient care pathways for pregnancy in rare and complex rheumatic diseases: results from an international survey. J Rheumatol 50:934\u2013938. https:\/\/doi.org\/10.3899\/jrheum.220773","journal-title":"J Rheumatol"},{"key":"6174_CR20","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/annrheumdis-2015-208840","volume":"75","author":"C G\u00f6testam Skorpen","year":"2016","unstructured":"G\u00f6testam Skorpen C, Hoeltzenbein M, Tincani A et al (2016) The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis 75:795\u2013810. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208840","journal-title":"Ann Rheum Dis"},{"key":"6174_CR21","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1136\/ard-2022-223016","volume":"81","author":"E Loza","year":"2022","unstructured":"Loza E, Carmona L, Woolf A et al (2022) Implementation of recommendations in rheumatic and musculoskeletal diseases: considerations for development and uptake. Ann Rheum Dis 81:1344\u20131347. https:\/\/doi.org\/10.1136\/ard-2022-223016","journal-title":"Ann Rheum Dis"},{"key":"6174_CR22","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/acr.24130","volume":"72","author":"LR Sammaritano","year":"2020","unstructured":"Sammaritano LR, Bermas BL, Chakravarty EE et al (2020) 2020 American College of Rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases. Arthritis Care Res (Hoboken) 72:461\u2013488. https:\/\/doi.org\/10.1002\/acr.24130","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"6174_CR23","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1002\/acr.25558","volume":"77","author":"A Chin","year":"2025","unstructured":"Chin A, Terrett A, Kwon M, Whittle S, Hill C (2025) Recommendations for the use of disease-modifying antirheumatic drugs in pregnancy and reproductive health for patients with rheumatic disease: a scoping review. Arthritis Care Res (Hoboken) 77:1273\u20131281. https:\/\/doi.org\/10.1002\/acr.25558","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"6174_CR24","doi-asserted-by":"publisher","first-page":"3711","DOI":"10.1093\/rheumatology\/keab894","volume":"61","author":"K Hellgren","year":"2022","unstructured":"Hellgren K, Secher AE, Glintborg B et al (2022) Pregnancy outcomes in relation to disease activity and anti-rheumatic treatment strategies in women with rheumatoid arthritis: a matched cohort study from Sweden and Denmark. Rheumatology (Oxford) 61:3711\u20133722. https:\/\/doi.org\/10.1093\/rheumatology\/keab894","journal-title":"Rheumatology (Oxford)"},{"key":"6174_CR25","doi-asserted-by":"publisher","first-page":"557","DOI":"10.31138\/mjr.120225.rai","volume":"36","author":"SA Emadi","year":"2025","unstructured":"Emadi SA, Satti E, Hadwan N et al (2025) Impact of rheumatoid arthritis on pregnancy outcomes: increased risks of abortion and low birth weight in a prospective case-control study. Mediterr J Rheumatol 36:557\u2013565. https:\/\/doi.org\/10.31138\/mjr.120225.rai","journal-title":"Mediterr J Rheumatol"},{"key":"6174_CR26","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/03009742.2024.2303832","volume":"53","author":"LK Flatman","year":"2024","unstructured":"Flatman LK, Malham\u00e9 I, Colmegna I, B\u00e9rard A, Bernatsky S, Vinet \u00c9 (2024) Tumour necrosis factor inhibitors and serious infections in reproductive-age women and their offspring: a narrative review. Scand J Rheumatol 53:295\u2013306. https:\/\/doi.org\/10.1080\/03009742.2024.2303832","journal-title":"Scand J Rheumatol"},{"key":"6174_CR27","doi-asserted-by":"publisher","first-page":"191","DOI":"10.5152\/eujrheum.2022.20012","volume":"9","author":"A Pluma","year":"2022","unstructured":"Pluma A, Alsina L, Baniandres O et al (2022) Multidisciplinary models for pregnancy care in patients with rheumatic diseases: clinical experiences and experts opinion. Eur J Rheumatol 9:191\u2013196. https:\/\/doi.org\/10.5152\/eujrheum.2022.20012","journal-title":"Eur J Rheumatol"},{"key":"6174_CR28","doi-asserted-by":"publisher","first-page":"566","DOI":"10.31138\/mjr.200825.ser","volume":"36","author":"S Chandrashekara","year":"2025","unstructured":"Chandrashekara S, Shenoy P, Ghosh A et al (2025) Reproductive outcomes and fertility patterns in women with systemic sclerosis: a multicentre observational study. Mediterr J Rheumatol 36:566\u2013572. https:\/\/doi.org\/10.31138\/mjr.200825.ser","journal-title":"Mediterr J Rheumatol"},{"key":"6174_CR29","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1186\/s12909-025-07883-4","volume":"25","author":"S Ali","year":"2025","unstructured":"Ali S, Sethi A, Soltani A, Nazar Z (2025) Impact of continuing professional development (CPD) on patient outcomes: a systematic scoping review. BMC Med Educ 25:1284. https:\/\/doi.org\/10.1186\/s12909-025-07883-4","journal-title":"BMC Med Educ"},{"key":"6174_CR30","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4103\/jmss.jmss_37_23","volume":"14","author":"M Zhang","year":"2024","unstructured":"Zhang M, Wu S, Ibrahim MI, Noor SSM, Mohammad WMZW (2024) Significance of ongoing training and professional development in optimizing healthcare-associated infection prevention and control. J Med Signals Sens 14:13. https:\/\/doi.org\/10.4103\/jmss.jmss_37_23","journal-title":"J Med Signals Sens"},{"key":"6174_CR31","doi-asserted-by":"publisher","first-page":"857","DOI":"10.3899\/jrheum.230139","volume":"50","author":"MH Radhakrishna","year":"2023","unstructured":"Radhakrishna MH, Kayidhi S, Ravindran V (2023) Optimizing care for pregnancy in rheumatic diseases: barriers and potential solutions. J Rheumatol 50:857\u2013859. https:\/\/doi.org\/10.3899\/jrheum.230139","journal-title":"J Rheumatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-026-06174-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-026-06174-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-026-06174-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T07:16:51Z","timestamp":1784272611000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-026-06174-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":31,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["6174"],"URL":"https:\/\/doi.org\/10.1007\/s00296-026-06174-5","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"assertion":[{"value":"5 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"154"}}